About this trial
This prospective multicenter validation study aimed to evaluate the predictive performance of a previously developed model for MDRGNB infection in ICU patients.
Eligibility criteria
Qualifiers
Age ≥18 years;
ICU stay ≥48 hours;
At least one clinical microbiological specimen collected and submitted for testing within 48 hours of ICU admission, with the first submission time designated as the index time;
Core predictive variables of the model extractable from electronic medical records or laboratory information systems.
Disqualifiers
For patients with multiple ICU admissions, only the first ICU stay was retained;
Missing or indeterminate primary outcome;
Missing key predictive variables that could not be handled according to prespecified rules.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Lead sponsor
Ruijin Hospital
Collaborator
Zhejiang Hospital
Collaborator